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Mutations in genes associated with the U4/U6-U5 small nuclear ribonucleoprotein (snRNP) complex of the spliceosome are implicated
in autosomal-dominant retinitis pigmentosa (adRP), a group of progressive retinal degenerative disorders leading to visual impairment,
loss of visual ﬁeld, and even blindness. We recently assigned a locus (RP33) for adRP to 2cen-q12.1, a region that harbors the SNRNP200
gene encoding hBrr2, another U4/U6-U5 snRNP component that is required for unwinding of U4/U6 snRNAs during spliceosome
activation and for disassembly of the spliceosome. Here, we report the identiﬁcation of a missense mutation, c.3260C>T (p.S1087L),
in exon 25 of the SNRNP200 gene in an RP33-linked family. The c.3260C>T substitution showed complete cosegregation with the reti-
nitis pigmentosa (RP) phenotype over four generations, but was absent in a panel of 400 controls. The p.S1087Lmutation and p.R1090L,
another adRP-associated allele, reside in the ‘‘ratchet’’ helix of the ﬁrst of two Sec63 domains implicated in the directionality and proc-
essivity of nucleic acid unwinding. Indeed, marked defects in U4/U6 unwinding, but not U4/U6-U5 snRNP assembly, were observed in
budding yeast for the analogous mutations (N1104L and R1107L) of the corresponding Brr2p residues. The linkage of hBrr2 to adRP
suggests that the mechanism of pathogenesis for splicing-factor-related RP may fundamentally derive from a defect in hBrr2-dependent
RNA unwinding and a consequent defect in spliceosome activation.Introduction
Recent progress in disease-gene identiﬁcation for retinitis
pigmentosa (RP [MIM268000]) has established the involve-
ment of nuclear pre-messenger RNA (pre-mRNA) splicing as
one important mechanism in the disease etiology and has
shed light on the spliceosome machinery itself. RP is one
of the most common inherited causes of blindness, with
a prevalence of 1 in 3500 live births.1 The disease process
involves pigmentation and atrophy in the mid-periphery
of the retina, leading to symptoms of night blindness,
restriction, and gradual loss of the peripheral visual ﬁeld.
The disease primarily affects rod photoreceptors, whereas
impairment of the cone-receptor function is secondary to
the disease process.2 RP has a strong genetic background,1
with 19 disease genes identiﬁed for the autosomal-domi-
nant forms (adRP) (RetNet database). Notably, four of these
genes are involved in the pre-mRNA splicing process,
including precursor mRNA processing factor 8 (PRPF8
[MIM 607300]),3 PRPF31 (MIM 606419),4 PRPF3 (MIM
607301),5 and PIM1-associated protein (RP9 or PAP1
[MIM 607331]).6
We previously assigned an adRP locus, RP33 (MIM
610359), to chromosomal region 2cen-q12.1 by linkage
analysis in a large family.7 On the basis of recombinantThe Americanmapping, the critical interval was deﬁned as a 9.46 Mb
region,7 with ﬁve candidate genes (Figure 1), of which
SEMA4C (MIM 604462), CNGA3 (MIM 600053), and
HNK1ST (MIM 603376) were previously excluded.7
The U5 snRNP 200 kDa helicase gene SNRNP200 (MIM
601664; also known as ASCC3L1), which lies within the
RP33 locus, encodes a 2136 amino acid protein, known as
hBrr2,8 composed of two DExD/H box ATPase domains,9
each followed by a Sec63 domain.10,11 hBrr2 plays a central
and conserved role innuclear pre-mRNA splicing,8,12–14 the
process by which introns are removed and ﬂanking exons
are ligated.
Pre-mRNA splicing is catalyzed by the spliceosome,
which consists of the small nuclear RNAs (snRNAs) U1,
U2, U4, U6, and U5, together with approximately 80
conserved proteins.15 During the spliceosome cycle, the
snRNAs undergo structural rearrangements that are critical
for intron recognition, catalysis, and recycling.16 In partic-
ular, a base-paired duplex of U4/U6 snRNAs, which is
required for assembly of the spliceosome on a pre-mRNA
substrate, unwinds in a key step during the catalytic activa-
tion of the spliceosome.17–19 Unwinding of U4/U6 permits
formation of the mutually exclusive U2/U6 base-paired
interaction, which makes up a key component of the cata-
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Figure 1. Schematic Representation of RP33 Mapping and Analyzed Genes
A physical map of the RP33 region in chromosomal region 2cen-q12.17 is shown in the middle, critical microsatellite markers are
indicated above, and physical distances (in Mb) are shown below. The adRP-affected family was reportedly linked to the region with
maximum LOD score at D2S2222,7 as indicated at the top (gray bar). RP33 is ﬂanked by D2S2159 and D2S1343, on the basis of unaf-
fected recombinants (black bar), and is ﬂanked by D2S329 and D2S2229, on the basis of affected recombinants (green bar).7 Candidate
genes within the 9.4 Mb RP33 region are shown below the physical map.spliceosome disassembly and U4 and U6 are reannealed for
subsequent rounds of splicing.24
In budding yeast, Brr2p, the ortholog of human hBrr2, is
required both for U4/U6 unwinding25 and for spliceosome
disassembly.26 Brr2 is thought to directly unwind U4/
U6,10,11,27,28 a reaction that requires the ﬁrst DExD/H box
ATPase domain;25,29 such domains function in many
RNA-dependent processes by binding RNA, hydrolyzing
ATP, andunwindingRNA.9Additionally,U4/U6unwinding
requires the ﬁrst Sec63 domain.10,11,26 Brr2p is a core
component of U4/U6-U5 small nuclear ribonucleoproteins
(snRNPs) and remains associated with the spliceosome
throughout the splicing process.15 Presumably for timing
of the activity of this central ATPase, Brr2p is regulated
by the GTPase Snu114p,26 ubiquitin,30 and Prp8p,10,11,28
which is ubiquitylated in the U4/U6-U5 snRNP.30 As for
hBrr2, three of the splicing factors linked to adRP are
components of the U4/U6-U5 triple snRNPs, including
the U4/U6 components PRPF31 and PRPF3 and the U5618 The American Journal of Human Genetics 85, 617–627, Novembcomponent PRPF8,15,31 and the fourth factor PAP1 interacts
with PRPF3.32 adRP, associated with mutations in splicing
genes, is presently regarded as resulting from defective
triple-snRNP assembly.33,34 However, adRP mutations in
PRPF8 affect not only triple snRNP assembly but also U4/
U6 unwinding,28 suggesting the involvement of comple-
mentary or alternative disease mechanisms.
Given the association of hBrr2 with adRP factors in the
context of the triple snRNP, we selected SNRNP200 as
a candidate forRP33. In this study,we report that amissense
alteration p.S1087L in the ﬁrst Sec63 domain of hBrr2 cose-
gregates with adRP in the RP33-linked family. A recent
crystal structure of budding yeast Brr2p localizes the equiv-
alent of S1087 (N1104) to the nucleic-acid-interacting face
of a ‘‘ratchet’’ helix implicated in the directionality and
processivity of duplex nucleic acid unwinding.10,11,35
Indeed, the brr2-N1104L mutation in yeast permitted
assemblyofU4/U6-U5snRNPsbutcompromisedunwinding
of U4/U6. Thus, our results support identiﬁcation ofer 13, 2009
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Figure 2. Identification of Missense Mutation c.3260C>T in Exon 25 of the SNRNP200 Gene Segregating Completely with the
Affected Phenotype in a Four-Generation adRP Family
(A) Pedigree of the kindred in which the RP33 locus was initially assigned.7 The genotypes C/T (heterozygous mutation) and C/C
(wild-type) are given below the pedigree symbols.
(B) Sequencing chromatograms from affected (top) and unaffected (bottom) family members, showing the c.3260C>T substitution in
exon 25 of SNRNP200 and corresponding wild-type sequence.
(C) Conﬁrmation of the c.3260C>T mutation by pyrosequencing. Genotypes are highlighted by blue color, as C/T in the presence of
mutation and as C/C in wild-type sequence.
(D) Fundus photography of the right eye of affected individual IV:5. Notably, bone-spicule-like pigmentary deposits (denoted by arrows)
were found in the peripheral retina, whereas the posterior retina is less affected (denoted by white box).p.S1087L as a pathogenic mutation and implicate the pre-
mRNA splicing gene SNRP200 in adRP. In a parallel study,
SNRP200 was similarly implicated in adRP by the nearby
mutationp.R1090L,36whichwe showalso permits assembly
ofU4/U6-U5 snRNPsbut compromisesU4/U6unwinding in
yeast. Importantly, our work suggests that a defect in Brr2p-
dependentduplexunwinding contributes to, if not accounts
for, the association of splicing genes with adRP.
Subjects and Methods
Retinitis Pigmentosa Patients and Controls
The adRP family studied was previously used for assignment of the
RP33 locus to the long arm of chromosome 2. This RP33-linkedThe Americanfamilywas clinically examined in Tianjin EyeHospital as described
in2006.7At a recent follow-up, individual IV:5,whowaspreviously
unaffected, presented symptoms and features in agreement with
affected status. In total, 12 affected and seven unaffected family
members, as well as six spouses, were included in the genetic anal-
yses of the present study (Figure 2). Furthermore, 137 affected cases
were studied, representing87probands inpreviously reportedadRP
families collected at the Human Genetics Center of the University
of Texas Health Science Center37 and 50 Chinese sporadic and
unrelated RP cases collected in the Hong Kong Eye Hospital and
the Prince of Wales Hospital in Hong Kong.38,39 Informed consent
was obtained from all case individuals for sample collection and
molecular analysis, and human studies were approved by local
ethical review boards in accordance with the Declaration of Hel-
sinki. Genomic DNA isolated from peripheral leukocytes was used
for direct sequencing and pyrosequencing analyses.Journal of Human Genetics 85, 617–627, November 13, 2009 619
Normal references constituted DNA samples from 400 unrelated
individuals with no personal or family history of RP, including
200 Chinese individuals and 200 individuals of different ethnic
backgrounds.
Genomic Sequencing of SNRNP200 and ADRA2B
SNRNP200 andADRA2Bwere sequenced in oneunaffected and two
affected familymembers (III:1, III:2, and III:8; Figure2),with theuse
of primer sequences and annealing conditions detailed in Table S1
(available online). Primers were designed so that they allowed
ampliﬁcation by polymerase chain reaction (PCR) of predicted
exons and exon-intron boundaries of the entire coding regions.
PCR amplicons were directly sequenced in both directions via
methods previously described7 andwere analyzed in an automated
ABI 3730GeneticAnalyzer system(AppliedBiosystems, FosterCity,
CA, USA) available at the KIGene facility of the Karolinska Institute
(KI) in Stockholm, Sweden. After the detection of a c.3260C>T
substitution, exon 25 was sequenced in all members of the RP33-
linked family, 137 adRP patients, and 400 unaffected controls.
Pyrosequencing
Pyrosequencing was performed for the speciﬁc verﬁciation of the
presence or absence of the c.3260C>T substitution in the RP33-
linked family. The three primers that were used included 50-AACG
TTCTTCTGCAAGCCTTCATC-30 (forward primer), 50-ACCTCGGT
TCAGGACAATTTCAAA-30 (reverse primer), and 50-ATGGTGTATG
TCACACAGT-30 (sequencing primer). The pyrosequencing assay
was carried out via the protocol recommended by the manufac-
turer,with theuseofPSQ96 (PyrosequencingAB,Uppsala, Sweden)
available at the KIGene facility of KI in Stockholm, Sweden.
Analyses of HeLa-Cell-Derived Samples
HeLa S3 cells (human cervical cancer cells) were kindly provided
by Dr. K-LWallin of KI and were used for DNA extraction followed
by genomic sequencing of exon 25. HeLa S3-cell-line-derived RNA
was purchased from Ambion (Ambion, Applied Biosystems) and
used for cDNA synthesis and subsequent sequencing of exon 24
to exon 26 with the use of primers detailed in Table S1.
Expression of SNRNP200 and Snrnp200
PCRwas performed for evaluation of the expression of SNRNP200 in
a commercial cDNA panel derived from multiple normal human
tissues (Clontech, Mountain View, CA, USA), including heart, brain,
placenta, lung, liver, skeletalmuscle, kidney, and pancreas. Similarly,
expression of Snrnp200 was also determined in different murine
tissues via reverse-transcriptase PCR (RT-PCR) analysis. C57BL/6
mice were sacriﬁced at 2 mo of age and different murine tissues
were dissected, including lung, kidney, brain, spleen, heart, liver,
retina, and RPE-choroid-sclera eye cup. Total RNA was isolated with
the TRIzol Plus RNA puriﬁcation system and cDNA was synthesized
with Superscript II Reverse Transcriptase (Invitrogen, Carlsbad, CA,
USA), inaccordancewith themanufacturer’s instructions.Primers are
detailed in Table S1 for human andmurine SNRNP200 and Snrnp200
andthehousekeepinggenesGAPDHandGapdh thatwereanalyzed in
parallel as a positive control. Animal experiments were approved by
the local ethical review board and conformed to the Guide for the
Care and Use of Laboratory Animals (see Web Resources).
S. cerevisiae Strains and Plasmids
Triple snRNPs were puriﬁed from yJPS1115 (BRR2), yJPS1378 (brr2-
N1104A), yJPS1379 (brr2-N1104L), yJPS1380 (brr2-N1104S), and620 The American Journal of Human Genetics 85, 617–627, NovemyJPS1383 (brr2-R1107L). These strains were generated by transfor-
mation of yJPS1114 (MATa his3D leu2D met15D ura3D brr2::LEU2
PRP28-TAP::KanMX pSN123)26 with the HIS3-marked plasmids
pPR13025 (BRR2), bJPS2383 (brr2-N1104A), bJPS2410 (brr2-
N1104L), bJPS2411 (brr2-N1104S), and bJPS2433 (brr2-R1107L)
and subsequent selection against the endogenous URA3-marked
BRR2 plasmid by the streaking of colonies onto 5-ﬂuroorotic
acid.40 Themutated plasmidswere generated byQuikchangemuta-
genesis (Stratagene) of pPR130 and conﬁrmed by sequencing.
Triple-snRNP Puriﬁcation
Triple snRNPs were puriﬁed with the use of TAP-tagged-Prp28p
essentially as described previously,26 with one exception: the
snRNPs were not eluted from the IgG-Sepharose beads but were
instead stored in an equal volume of Buffer D (20 mM HEPES
[pH7.9], 0.2 mM EDTA, 50 mM KCl, and 20% [v/v] glycerol).
U4/U6 Unwinding Assay
U4/U6unwindingassayswereperformedandanalyzedasdescribed
previously.30 In brief, puriﬁed triple snRNPswere incubated in stan-
dard splicing buffer41 at 4C or 20C, and unwinding was initiated
by the addition of 2 mM ATP.
Results
Identiﬁcation of a Missense SNRNP200 Mutation
in adRP
The selected candidate genes SNRNP200 and ADRA2B were
sequenced in one unaffected and two affected members of
the RP33-linked family. The analyses involved the entire
coding regions and exon-intron splice junctions. Disease-
associated nucleotide alterations were not revealed in
ADRA2B. However, for SNRNP200 a single base variation,
C>T, was observed at c.3260 in exon 25 (Figure 2). This
c.3260C>T substitution was predicted to give an amino
acid alteration from serine to leucine at amino acid residue
1087 (p.S1087L) of the encoded hBrr2 protein (Figure 3).
Extended sequencing of exon 25 in all available members
of the RP33-linked family revealed that c.3260C>T
(p.S1087L) cosegregated with the RP phenotype in
all affected members but was excluded from all unaffected
members (Figure 2A). Themutation statuswas subsequently
veriﬁed by direct analysis of the c.3260C>T substitution by
pyrosequencing, which conﬁrmed the presence of
c.3260C>T in all affected members (Figure 2C).
Complete penetrance for the c.3260C>T (p.S1087L)
Mutation
As previously reported, the RP33-linked family demon-
strated variable expression of RP phenotypes with rela-
tively late onset.7 In 2006, all affected family members,
as well as one unaffected familymember (IV:5), were found
to carry the disease-associated haplotype of the RP33
interval. This observation was in complete agreement
with the segregation of the SNRNP200 mutation observed
here. At a recent follow-up, it was observed that individual
IV:5 had developed decreased nighttime visual acuity at 17
years of age, which is similar to the onset ages of mostber 13, 2009
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Figure 3. Analysis of the SNRNP200 Gene and the c.3260C>T (p.S1087L) Mutation
(A) The SNRNP200 gene, including 45 exons, is illustrated at the top, and the mutated exon 25 is highlighted in red. The encoded hBrr2
protein includes 2136 amino acids and contains two DExD/H box ATPase domains (green) and two Sec63 domains (red). The p.S1087L
mutation resides in the ﬁrst Sec63 domain.
(B) Ubiquitous expression of human SNRNP200 and murine Snrnp200 demonstrated by PCR of cDNA samples. The expected product of
285 bp for human (top panel) and 491 bp for mouse (third panel) was found in all tested tissues. Human GAPDH and murine Gapdh
transcripts were analyzed in parallel as a positive control (second and bottom panels).
(C) Sequence alignment of hBrr2 from human (Hs), cow (Bt), horse (Ec), dog (Cf), mouse (Mm), rat (Rn), fruit ﬂy (Dm), worm (Ce), and
budding yeast (Sc). Conserved residues are shaded, the position of the mutated human S1087 residue in the RP33 family is boxed, and
the R1107 mutation36 is indicated by a line.affected members in the family. Consistently, bone-
spicule-like pigmentary deposits were observed in the local
peripheral retina of both eyes during funduscopy (Fig-
ure 2D). Altogether, these ﬁndings suggest that the
p.S1087Lmutation is associated with complete penetrance
of the adRP phenotype in this family.
Screening for c.3260C>T (p.S1087L) in adRP
Probands and Controls
According to the Human SNP databases (Ensembl and
HapMap), the c.3260C>Talteration has not been previously
reported in any population. However, c.3,260C>T
(p.S1087L) was reported as a conﬂict variation in one HeLa-
cell-derived cDNA clone (GenBank ID: gij45861371)42 but
not in others.8 Sequencing of exon 25 in HeLa S3-derived
samples showedthepresenceof theC/Tgenotype ingenomic
DNA and of the c.3260C>T (p.S1087L) alteration in cDNA
samples (data not shown). For further assessment of whetherThe Americanc.3260C>T (p.S1087L) is a rare polymorphism or a disease-
associated mutation, direct sequencing of exon 25 in 400
unaffected controls and 137 unrelated adRP probands was
carried out. This revealed the wild-type sequence c.3260C
in all cases, suggesting that c.3260C>T (p.S1087L) is
a disease-associated mutation in the RP33-linked family.
Expression of the SNRNP200 Gene
SNRNP200 expression was previously detected in one
retinal-derived cDNA library (NbLib0013) deposited in the
NEIbank database. We further assessed SNRNP200 gene
expression in other human tissues by routine PCR analyses
of a cDNA panel, using primers ﬂanking exons 4 to 6. The
housekeeping gene GAPDH was ampliﬁed in parallel as
a positive control. As illustrated in Figure 3B (upper two
panels), the PCR reaction generated single products of the
expected sizes of 285 bp for SNRNP200 and of 299 bp for
GAPDH in all tissues. These results demonstrate thatJournal of Human Genetics 85, 617–627, November 13, 2009 621
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Figure 4. Two adRP Mutations in Budding Yeast Brr2p Impair Unwinding of U4/U6 snRNAs
(A) The mutant yeast strains brr2-N1104L, brr2-N1104S, and brr2-R1107L were assayed for growth relative to wild-type. Strains were
grown to log phase, serially diluted, spotted onto rich media, and grown at 30C (1 day) or 15C (7 days).
(B) Triple snRNPs puriﬁed fromwild-type BRR2 (lanes 1–6), mutant brr2-N1104L (lanes 7–12), or mutant brr2-R1107L (lanes 13–18) were
assayed for their ability to unwind U4/U6 snRNAs in the presence of ATP at 20C. Quenched samples were cold-phenol extracted, RNA
was resolved by native gel electrophoresis, and the U4 and U6 snRNAs were detected by RNA blotting analysis. For comparison, lane 19
shows a sample from brr2-R1107L that was hot-phenol extracted.
(C) Quantiﬁcation of U4/U6 unwinding at 20C by triple snRNPs puriﬁed from BRR2 (black closed diamonds), the RP33 mutant brr2-
N1104L (blue closed triangles), and the other adRP mutant brr2-R1107L (orange closed circles). Data from (B) and data not shown
were quantiﬁed and plotted. Error bars represent the standard deviation from three or more experiments.
(D) The SNRNP200 adRP mutations reside in a ‘‘ratchet’’ helix of the Sec63 domain of Brr2p implicated in promoting the directionality
and processivity of unwinding. A close-up of the ‘‘ratchet’’ helix of the corresponding domain in Hel308 (pdb 2P6R35) (red) is shown
with the ‘‘ratchet’’ helix at the top. Residues of the ratchet helix that face and/or interact with nucleic acid (cyan) are highlighted
(yellow). T596 corresponds to N1104 in yeast and to the RP33 residue S1087 in humans. W599 corresponds to R1107 in yeast and to
the adRP residue R1090 in humans.36 R592 corresponds to F1100 in yeast and to Y1083 in humans.SNRNP200 is expressed in a wide range of human tissues.
A similar expression pattern of the Snrnp200 gene was
detected in murine tissues, as shown in Figure 3B (lower
two panels). A 491 bp band representing an RT-PCR ampli-
con ﬂanking exons 24 to 26 of Snrnp200was detected in all
tissues, including, among others, the retina.
Evolutionary Conservation of p.S1087L
Screening of SNRNP200 orthologs with the use of the
Ensembl protein blast database revealed that S1087 is
extremely well conserved between all mammalian species,
D. melanogaster, and C. elegans (Figure 3C). Application of
the polymorphism-phenotyping program PolyPhen for
prediction of functional consequences resulted in a posi-
tion-speciﬁc independent counts (PSIC) proﬁle score of
2.45 for the p.S1087L amino acid change. This value indi-
cates that p.S1087L is likely to functionally impair the622 The American Journal of Human Genetics 85, 617–627, NovemhBrr2 protein,43 thus suggesting that p.S1087L is a func-
tional mutation.
adRP Mutations Impair U4/U6 snRNA Unwinding
in Budding Yeast
To investigatewhether theRP33mutationmightcompromise
the catalytic activity of hBrr2, we utilized an assay for U4/U6
unwinding from budding yeast.25 With this assay, we tested
the impact of three mutations—N1104L, corresponding to
the RP33 mutation; N1104S, corresponding to the natural
human residue at this position; and N1104A. None of these
mutations compromised growth (Figure 4A, data not shown),
except subtly at low temperature on minimal media (15C;
data not shown). For the unwinding assay, we ﬁrst fractioned
yeast extract on a glycerol gradient and then puriﬁed U4/U6-
U5 triple-snRNP particles from peak fractions by using TAP-
taggedPrp28p.26Noneof themutationsaltered themigrationber 13, 2009
which has been modeled in yeast on the basis of theof snRNAson the glycerol gradient, andnone altered the ratio
or reduced the levels of snRNAs copuriﬁed with Prp28p (data
not shown). Thus, at least at 30C, the mutations do not
compromise triple-snRNP assembly, which has been sug-
gested as a causative defect of other adRP mutations.33,34
Although aphenotypic in the aforementioned assays, the
N1104Lmutation conferred a striking defect in ATP-depen-
dent U4/U6 unwinding (Figures 4B and 4C; Figure S1). For
reference, at 20C, the wild-type triple snRNPs unwound
U4/U6 rapidly, achieving 50% unwinding at 20 s (Figures
4B and 4C). In contrast, the RP33 mutation, N1104L,
slowed unwinding signiﬁcantly, failing to achieve even
50% unwinding at 300 s (Figures 4B and 4C). At 4C, the
wild-type triple snRNPs similarly unwound U4/U6 rapidly,
achieving 50% unwinding at 50 s (Figures S1A and S1B),
and the mutation to the human residue, N1104S, slowed
unwinding only slightly, permitting 50% unwinding by
75 s (Figures S1A and S1B). In contrast, the RP33mutation,
N1104L, slowed unwinding signiﬁcantly, preventing even
50% unwinding after 300 s (Figures S1A and S1B), and the
N1104A mutation also slowed unwinding but permitted
50% unwinding at 260 s (Figures S1A and S1B). Thus, the
N1104L RP mutation in budding yeast permits triple-
snRNP assembly but impairs RNA unwinding.
While thismanuscriptwasunder revision, a separate study
was published, reporting a second Chinese family in which
adRP cosegregated with a mutation in SNRNP200.36 In this
family, the average age of onset was 7–8 years,36 rather
than the16–18years observed forRP33.7Notably, thismuta-
tion (p.R1090L) is also found in the ﬁrst Sec63 domain and
resides on the same face of the putative ratchet helix as
p.S1087L, and the equivalent residue in Hel308 (W599,
Figure 4D) has been proposed to contribute to ratchet-
ing.10,11,35 R1090 is strictly conserved from humans to
budding yeast (Figure 3C), and amutation of the equivalent
residue in yeast (R1107A) impairs ATPase and U4/U6
unwinding activities of puriﬁed Brr2p and U4/U6
unwinding within U4/U6-U5 snRNPs.10,26 To investigate
the possible consequences of the p.R1090L mutation in
hBrr2p, we investigated the equivalent R1107L mutation
in yeast. In contrast to the N1104L mutation, the R1107L
mutation conferred a strong cold-sensitive defect on rich
media (Figure 4A). Like the N1104L mutation, the R1107L
mutation did not compromise U4/U6-U5 snRNP assembly
in vivo at 30C (data not shown), in agreement with its
normal growth phenotype at that temperature (Figure 4A).
At both 4C and 20C, the R1107L mutation permitted
even less unwinding thandid theN1104Lmutation (Figures
4B and 4C; Figure S1C). Thus, both adRP mutations in
SNRNP200conferdefects inU4/U6unwinding,proportional
to the severity of the disease resulting from thesemutations.
Discussion
In this study, we report the identiﬁcation of a single amino
acid substitution (p.S1087L) of the SNRNP200 gene in fourThe Americangenerations of a Chinese family, previously linked to the
critical region for the adRP locus RP33 (Figure 1). The
p.S1087L mutation cosegregates with the RP phenotype
in all affected members in the family (Figure 2) and was
not identiﬁed in a panel of 400 normal controls. p.S1087
is absolutely conserved among all mammals, as well as fruit
ﬂies and worms, suggesting that it has an important func-
tion in the encoded hBrr2 protein. The mutation falls
within the ﬁrst Sec63 domain of hBrr2, implicating a defect
in RNA unwinding. Indeed, in native U4/U6-U5 snRNP
particles from budding yeast, the analogous mutation
(N1104L) impaired U4/U6 unwinding (Figure 4; Figure S1),
a critical step in the catalytic activation of the spliceosome.
Additionally, a newly identiﬁed RP locus similarly links to
a mutation (p.R1090L) in SNRNP200,36 and we show that
the equivalent mutation in budding yeast also compro-
mises U4/U6 unwinding (Figure 4; Figure S1). These data
implicate a defect in RNA unwinding as the basis of
SNRNP200-associated adRP and implicate the contribution
of a similar mechanism for adRP mutations in other
splicing genes.
The substitution c.3260C>T (p.S1087L) was not
revealed in 137 adRP probands, suggesting that mutation
of exon 25 is a relatively uncommon cause of adRP. How-
ever, for full evaluation of the prevalence of SNRNP200
mutations in adRP, mutation screening by sequencing of
the entire coding region and splice junctions of SNRNP200
is required in adRP families. Furthermore, because a direct-
sequencing-based technique is limited in the detection of
large deletions and/or insertions, which are relatively
common for other adRP genes,44 complementary tech-
niques, such as multiplex ligation-dependent probe ampli-
ﬁcation (MLPA),mayalsobe required. Indeed, thediscovery
of a second adRPmutation (R1090L) in SNRNP200 suggests
that more will be found.36
Unexpectedly, c.3260C>T (p.S1087L) has been
described in a HeLa-cell-derived cDNA clone42 and was
also observed here in the heterozygous state in DNA and
cDNA samples of HeLa S3 cells. The HeLa cells were estab-
lished more than 50 years ago from an ovarian carcinoma
of a woman who died at 31 years of age. It is presently not
possible to determine whether she carried c.3260C>T
(p.S1087L) at the constitutional level, whether it was
acquired during ovarian cancer development, or whether
it occurred during long-term cell culturing as an artifact
or growth-promoting aberration.
To investigate the mechanism of pathogenesis for RP33,
we tested whether S1087L impairs RNA unwinding, given
that hBrr2 and its yeast ortholog directly unwind duplex
RNA10,11,27,28 and yeast Brr2p unwinds U4/U6 snRNAs
within the U4/U6-U5 snRNP.25,26,30 hBrr2 is composed of
a tandem repeat of a DExD/H box domain followed by
a Sec63 domain (Figure 3). In yeast Brr2p, only the ﬁrst
repeat performs a catalytic role;10,29 the second repeat
functions in protein binding and regulation by Prp8.10,45
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structure of the second Sec63 domain, which shows
striking similarity with a subdomain of Hel308.10,11,35
On the basis of this Sec63 domain model, the yeast equiv-
alent of p.S1087 (N1104) falls within the ‘‘ratchet’’ helix on
a face that interacts with nucleic acid. Furthermore, N1104
is predicted to be sandwiched between F1100 and R1107,
and the equivalent residues in Hel308, R592 and W599,
respectively (Figure 4D), were hypothesized to perform
a ratchet function to promote directional and processive
unwinding.35 In agreement with this hypothesis, the
mutation R1107A in yeast Brr2p dramatically reduces the
ATPase, U4/U6 unwinding, and spliceosome-disassembly
activities of Brr2p.10,26 Moreover, U4/U6 unwinding was
also decreased by the R1107L mutation, corresponding to
the adRP mutation p.R1090L in hBrr2,36 and by the neigh-
boring N1104L mutation, corresponding to the adRP
mutation p.S1087L in hBrr2 (Figure 4; Figure S1). There-
fore, our data emphasize the importance of the ratchet
helix in U4/U6 unwinding and implicate a defect in U4/
U6 unwinding in adRP.
The p.S1087L and p.R1090L ratchet-helix mutations
could compromise U4/U6 unwinding by either compro-
mising the inherent unwinding activity of hBrr2 or compro-
mising the regulation of hBrr2. Because the equivalent of
residues S1087 and R1090 in Hel308 contact nucleic acid
fromadomainessential forduplexunwinding,10,11,35muta-
tions in these residues of hBrr2 may very well compromise
its inherent unwinding activity. Indeed, the Sec63 domain
harboring these residues is associated with the catalytically
active DExD/H box domain of yeast Brr2p,10,11,29 and the
R1107A mutation in yeast Brr2p (at the equivalent of posi-
tion R1090 in hBrr2) compromises U4/U6 unwinding by
puriﬁed Brr2p, suggesting that the adRP mutations in this
ratchet helix cripple the inherent unwinding activity of
Brr2p.10 However, given that Brr2p is regulated by the
guanine nucleotide state of the GTPase Snu114p,26 by the
ubiquitylation state of the U4/U6-U5 snRNP,30 and by
Prp8p,28 the adRP mutations could also or alternatively
compromise the regulation of hBrr2. Indeed, regulation
of Brr2p by Prp8p is mediated by the C-terminal Sec63
domain,10,45 thereby implicating additional regulatory
interactions within Brr2p between the C-terminal Hel308
module, which includes the C-terminal Sec63 domain,
and the activeN-terminalHel308module; such interactions
may be compromised by the adRP mutations. Resolving
whether adRPmutations affect inherent unwinding activity
or regulation of hBrr2 requires further study.
The p.S1087L and p.R1090L mutations could compro-
mise a cell in several ways. First, they could decrease the
expression of spliced genes overall or for certain genes by
disrupting the splicing cycle, either by impeding U4/U6
unwinding and, consequently, spliceosome activation or
by impeding spliceosome disassembly and, consequently,
spliceosome recycling, although the adRP genes PRPF31
and PRPF3 are unlikely to play roles in spliceosome disas-
sembly. Additionally, as suggested for the other splicing-
related adRP mutations, p.S1087L and p.R1090L could624 The American Journal of Human Genetics 85, 617–627, Novemcompromise assembly of the U4/U6-U5 snRNP, although
we have found no evidence that corresponding mutations
N1104L and R1107L compromise assembly in budding
yeast. Second, the hBrr2 mutation may also impair proof-
reading of pre-mRNA splicing, thereby compromising
the ﬁdelity of gene expression. Three of eight DExD/H
box ATPases required for splicing have been shown to
function in proofreading.46–48 It is anticipated that
Brr2p will also function in proofreading by prematurely
unwinding U4/U6 or prematurely disassembling the
spliceosome to reject incorrect splicing substrates. Such
branched pathways are in competition with productive
splicing and are consequently quite sensitive to muta-
tions. Finally, the p.S1087L and p.R1090L mutations
could compromise an as-yet-undeﬁned function that lies
outside of splicing.
Interestingly, the earlier onset of adRP in individuals
with the p.R1090L mutation (7–8 years)36 as compared to
those with the p.S1087L mutation (16–18 years)7 corre-
lates with the stronger cold-sensitive growth defect and
stronger U4/U6-unwinding defect associated with the
equivalent R1107L mutation, as compared to the N1104L
mutation, in budding yeast (Figure 4). This correlation
supports the utility of budding yeast as a model organism
for investigation of adRP mutations. Furthermore, the
correlation provides additional evidence that a defect in
U4/U6 unwinding contributes to, if not accounts for,
adRP resulting from mutations in SNRNP200.
The SNRNP200, PRPF8, PRPF3, and PRPF31 gene prod-
ucts are all triple-snRNP components,15,31 and PAP1 binds
PRPF3 to negatively regulate splicing,32,49 suggesting
a common mechanism for pathogenesis. The prevailing
hypothesis has been that RP mutations in each of these
genes compromise triple-snRNP assembly. For example,
a previous study suggested that mutations in PRPF8 may
cause RP by disrupting the nuclear association of Brr2p
with the U5 snRNP and, consequently, the assembly of
the triple snRNP.33 In agreement with this point, another
recent study demonstrated that PRPF8 mutations in yeast
Prp8p compromise binding of a C-terminal fragment of
Prp8p to Brr2p.28 However, this study also demonstrated
that the C-terminal fragment of Prp8p stimulates Brr2p-
dependent RNA unwinding and that PRPF8 RP mutations
compromised unwinding. Although it is difﬁcult to
uncouple the unwinding defects from binding defects,
this study suggested that RP may result from a defect in
spliceosome activation in addition to or instead of a defect
in triple-snRNP assembly. Our own data solidify this
hypothesis, because the N1104L and R1107L mutations
in yeast Brr2p permit triple-snRNP assembly but compro-
mise U4/U6 unwinding (Figure 4; Figure S1; also, data
not shown). Prp3p (RP11) binds U4/U6 but may also
promote its unwinding, because Prp3p interacts by two-
hybrid analysis with Snu66p, which itself interacts with
Brr2p.42 PAP1, as a factor that interacts with Prp3p, could
modulate such an unwinding role for Prp3p.32 Prp31p
interacts with U4 but also with Prp6p, which interactsber 13, 2009
with Brr2p, potentially implicating a role for Prp31p
in unwinding. Consistent with a role in U4/U6
unwinding, both Prp3p and Prp31p dissociate upon
U4/U6 unwinding.15 Thus, in addition to or instead of
compromising triple snRNP assembly, each of the RPmuta-
tions in splicing genes may compromise Brr2p-dependent
U4/U6 unwinding.
Diverse RP phenotypes50 are frequently observed in asso-
ciation with mutations in adRP genes involved in the pre-
mRNA splicing process. Mutations of PRPF8 and PRPF3
generally lead tomore severe phenotypes,3,51 in agreement
with type 1 expression with early disease onset and diffuse
retinal involvement. By contrast, mutations of PRPF31 and
PAP1 have been observed in type 2 expression, with late
onset and regional retinal involvement, or showed variable
intrafamilial expression.4,52,53 The RP33 family affected by
the p.S1087L mutation of SNRNP200, reported here, pre-
sented clinical expression suggesting type 2 and intrafami-
lial variable phenotype,7 whereas the p.R1090L mutation
led to a more quickly developed phenotype,36 more likely
ﬁtting with type 1. Thus, the variable severity of the retinal
phenotypes in adRP may not only depend on the disease
gene involved but also result from the type and conse-
quence of the speciﬁc mutation involved.
Why do RP mutations in splicing genes cause only
retinal phenotypes if they manifest as pre-mRNA splicing
defects? One hypothesis rests on the fact that the retina
is a highly metabolically active tissue. Large amounts of
opsin are synthesized every second,54 and the outer
segments of photoreceptors are rapidly renewed. The
photoreceptors may show the highest demand for pre-
mRNA splicing among all cell types, and RP mutations
may compromise the efﬁciency of splicing. Hence, the
reduced splicing efﬁciency after a heterozygous mutation
could be sufﬁcient in other tissues but insufﬁcient in the
retina. In an alternative hypothesis, retinal cells may be
particularly demanding on the ﬁdelity mechanisms of
splicing, perhaps because of errors resulting from light-
induced damage or efﬁcient synthesis at the expense of
speciﬁcity. In this case, RP would stem from a defect in
a putative ﬁdelity role for Brr2. Finally, RP mutations in
splicing genes may play a role outside of splicing that is
speciﬁc to the retina.
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